A very large diversity space of synthetically accessible compounds for use with drug design programs
Journal of Computer-Aided Molecular Design2005Vol. 19(1), pp. 47–63
Citations Over TimeTop 10% of 2005 papers
С. М. Никитин, Наталья Владимировна Зайцева, О. В. Демина, Vera Solovieva, Evgeny Mazin, Sergey Mikhalev, Maxim Smolov, Anatoly R. Rubinov, Peter K. Vlasov, Dmitry Lepikhin, Denis Khachko, Valery V. Fokin, Cary Queen, Viktor Zosimov
Related Papers
- → Fragment‐based drug discovery—the importance of high‐quality molecule libraries(2022)129 cited
- → Chemical Space Mimicry for Drug Discovery(2017)112 cited
- → The Growing Importance of Chirality in 3D Chemical Space Exploration and Modern Drug Discovery Approaches for Hit-ID(2021)73 cited
- → Green Drug Discovery: Novel Fragment Space from the Biomass-Derived Molecule Dihydrolevoglucosenone (CyreneTM)(2023)10 cited
- → Fragment-based screening with natural products for novel anti-parasitic disease drug discovery(2019)27 cited